InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Nathanielsz James Andrew, Chief Financial Officer. Insider active across 1 companies, notably Propanc Biopharma, Inc.. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 17 August 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
05,928,000 shares0
Common stock, par value $0.001
SEC:0001493152-21-020758·
05,928,000 shares0
Common stock, par value $0.001
SEC:0001493152-21-020758:0·
2 of 2 declarations
About Nathanielsz James Andrew
James Andrew Nathanielsz is the CEO and CFO at Propanc Biopharma, Inc. In this dual role, he oversees the company's operations as well as its financial management. His expertise is crucial to ensure the viability and growth of Propanc.
